Thermo Fisher Scientific (TMO) offers growth potential with diverse revenue streams, fair valuation, and strong CAGR ...

Respondents agreed that the level of risk in pharmaceutical supply chains has increased across the board since 2023, although perceptions about the degree of escalation vary. Fifty-six (56%) percent ...

McKesson's strategic growth in oncology, biopharma and tech drives momentum in 2025. Will MCK overcome its sustaining challenges with robust finances and innovation?

Series Recaps Biopharma, MedTech, and Science Trends and Breakthroughs That Shaped the Year LONDON, Jan. 16, 2025 /PRNewswire/ -- BioWorld published by Clarivate Plc (NYSE:CLVT), a leading ...

BioWorld™ published by Clarivate Plc (NYSE:CLVT), a leading global provider of transformative intelligence, has released its highly anticipated 2024 Year in Review series. This multipart special ...

Amid ongoing geopolitical changes, India and the ASEAN region are emerging as key players in global trade. India's trade is ...

Press Release Distributed by ABNewswire.com To view the original version on ABNewswire visit: The Biopharmaceutical Contract ...

Biopharma innovator Alchemab Therapeutics, whose labs are in Cambridge UK, is collaborating with multinational pharma giant ...

UK-based Alchemab Therapeutics, a biopharma seeking to identify and develop naturally occurring therapeutic antibodies from ...

The biomanufacturer's job cuts follow a December announcement to let go of 105 employees at its Florida facility.

Neuromodulatory neural mechanisms behind contextual processing are not fully understood. Here, the authors show how spatiotemporal dynamics of locus coeruleus-norepinephrine release in dentate ...

Following a fresh round of job cuts in December, CDMO National Resilience is carrying its downsizing efforts into 2025. | ...